These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 35438)

  • 41. [Double-blind study of treatment with SF 68 or with antibiotics in acute enteritis in adults].
    Alvisi V; Tralli M; Loponte A; Pavani F; Massari M
    Clin Ter; 1982 Jun; 101(6):581-6. PubMed ID: 6751663
    [No Abstract]   [Full Text] [Related]  

  • 42. [Prevention of recurrence by salazosulfapyridine (azulfidine) therapy in Crohn's disease. A double blind study].
    Ewe K; Holtermüller KH; Baas U; Eckhart V; Krieg H; Kutzner J; Schäfer A
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():930-2. PubMed ID: 18856
    [No Abstract]   [Full Text] [Related]  

  • 43. [Sulfasalazine enema in acute left-sided ulcerative colitis (author's transl)].
    Frimberger E; Frühmorgen P; Kühner W; Ottenjann R
    MMW Munch Med Wochenschr; 1980 Sep; 122(36):1233-5. PubMed ID: 6108506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Shortcomings of the National Crohn's Disease Study: the exclusion of azathioprine without adequate trial.
    Korelitz BI; Present DH
    Gastroenterology; 1981 Jan; 80(1):193-6. PubMed ID: 6108892
    [No Abstract]   [Full Text] [Related]  

  • 45. [Incidence of inflammatory bowel diseases in the department of Puy-de-Dôme in 1993 and 1994. EPIMICI. Epidémiologie des Maladies Inflammatoires Cryptogenetiques de l'Intestin group].
    Flamenbaum M; Zénut M; Aublet-Cuvelier B; Larpent JL; Fabre P; Abergel A; Dapoigny M; Bommelaer G
    Gastroenterol Clin Biol; 1997; 21(6-7):491-6. PubMed ID: 9295977
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The National Cooperative Crohn's Disease Study.
    MacLean LD
    Can J Surg; 1980 Jan; 23(1):7-8. PubMed ID: 6102492
    [No Abstract]   [Full Text] [Related]  

  • 47. Letter: Value of uncontrolled trials in use of sulfasalazine.
    Goldstein F
    N Engl J Med; 1975 Aug; 293(9):455. PubMed ID: 239348
    [No Abstract]   [Full Text] [Related]  

  • 48. [Determination of sulfapyridine levels in serum--a possibility for the control of dose related therapy with sulfasalazine].
    Eitner K; Reinicke C; Hippius M
    Dtsch Z Verdau Stoffwechselkr; 1984; 44(6):282-8. PubMed ID: 6151895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome.
    Mogadam M; Dobbins WO; Korelitz BI; Ahmed SW
    Gastroenterology; 1981 Jan; 80(1):72-6. PubMed ID: 6108894
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is plasma level monitoring of sulfasalazine indicated in the treatment of Crohn's disease or ulcerative colitis?
    Fischer C; Klotz U
    Ther Drug Monit; 1980; 2(2):153-8. PubMed ID: 6132473
    [No Abstract]   [Full Text] [Related]  

  • 51. Disodium cromoglycate in the treatment of ulcerative colitis and Crohn's disease.
    Binder V; Elsborg L; Greibe J; Hendriksen C; Høj L; Jensen KB; Kristensen E; Madsen JR; Marner B; Riis P; Willumsen L
    Gut; 1981 Jan; 22(1):55-60. PubMed ID: 6780414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparative study of metronidazole and sulfasalazine in active, not severe, ulcerative colitis. An Israeli multicenter trial.
    Gilat T; Suissa A; Leichtman G; Delpre G; Pavlotzky M; Grossman A; Fireman Z
    J Clin Gastroenterol; 1987 Aug; 9(4):415-7. PubMed ID: 2888801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [7 clinics evaluate metronidazole therapy in Crohn's disease].
    Lakartidningen; 1976 Nov; 73(48):4196-7. PubMed ID: 11371
    [No Abstract]   [Full Text] [Related]  

  • 54. Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis.
    Dickinson RJ; O'Connor HJ; Pinder I; Hamilton I; Johnston D; Axon AT
    Gut; 1985 Dec; 26(12):1380-4. PubMed ID: 3910524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Side effects of salicylazosulfapyridine therapy].
    Miller B
    Dtsch Med Wochenschr; 1980 Nov; 105(46):1596-7. PubMed ID: 6108200
    [No Abstract]   [Full Text] [Related]  

  • 56. Reflections on the treatment of Crohn's disease, the NCCDS report, and on randomized clinical trials.
    Goldstein F
    J Clin Gastroenterol; 1980 Jun; 2(2):115-7. PubMed ID: 6108342
    [No Abstract]   [Full Text] [Related]  

  • 57. Biosimilars in Crohn's Disease and Ulcerative Colitis.
    Wolf DC
    Inflamm Bowel Dis; 2016 Apr; 22(4):994-7. PubMed ID: 26933749
    [No Abstract]   [Full Text] [Related]  

  • 58. The long-term prophylactic effect of salazosulphapyridine (Salazopyrin) in primarily resected patients with Crohn's disease. A controlled double-blind trial.
    Wenckert A; Kristensen M; Eklund AE; Barany F; Jarnum S; Worning H; Folkenborg O; Holtz A; Bonnevie O; Riis P
    Scand J Gastroenterol; 1978; 13(2):161-7. PubMed ID: 24891
    [No Abstract]   [Full Text] [Related]  

  • 59. Azathioprine has a very limited role in the treatment of Crohn's disease.
    Singleton JW
    Dig Dis Sci; 1981 Apr; 26(4):368-71. PubMed ID: 6113105
    [No Abstract]   [Full Text] [Related]  

  • 60. Antimycobacterial chemotherapy in inflammatory bowel disease.
    Picciotto A; Gesu GP; Schito GC; Testa R; Varagona G; Celle G
    Biomed Pharmacother; 1989; 43(2):141-3. PubMed ID: 2567614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.